Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Burcu, Caner"'
Autor:
Sercan Ön, Barış Köksal, Zafer Arık, Burcu Caner, Duygu Ercan Uzundal, Ozan Yazıcı, Burcu Arslan Benli, Eda Eylemer Mocan, Can Güngör, Zeynep Gülsüm Güç, Seval Akay, Merve Keskinkılıç, Hande Dik Avcı, Burçak Karaca Yayla, Burcu Çakar, Ulus Ali Şanlı
Publikováno v:
Current Oncology, Vol 31, Iss 11, Pp 6803-6813 (2024)
(1) Background: Metastatic L-type sarcomas (liposarcoma and leiomyosarcoma) are rare and have a poor prognosis. Trabectedin is an effective agent that can be used after anthracyclines. This study was designed to evaluate the real-life effectiveness a
Externí odkaz:
https://doaj.org/article/1d65b04e3d03422aac118901c122a732
Autor:
Burcu CANER, Sibel OYUCU ORHAN, Büşra ASAN, Birol OCAK, Ahmet Bilgehan ŞAHİN, Adem DELİGÖNÜL, Erdem ÇUBUKÇU, Türkkan EVRENSEL
Publikováno v:
Uludağ Üniversitesi Tıp Fakültesi Dergisi. 48:155-160
etkilerinin değerlendirilmesi amaçlanmıştır. Sarkom tanısıyla trabektedin tedavisi alan 16 hastanın dosyaları retrospektif olarak tarandı. Hastaların demografik özellikleri, tedavi süreleri, tedavi yanıtları, ilaç yan etkileri kaydedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f467c1104e42bed64c5f22aa4e353ff
https://doi.org/10.32708/uutfd.1066422
https://doi.org/10.32708/uutfd.1066422
Autor:
Birol OCAK, Ahmet Bilgehan ŞAHİN, Candan DEMİRÖZ ABAKAY, Seda SALİ, Bahar DAKİKİ, Gizem İŞLEK, Burcu CANER, Kemal ÖZERKAN, Adem DELİGÖNÜL, Erdem ÇUBUKÇU, Türkkan EVRENSEL
Publikováno v:
Volume: 48, Issue: 1 37-41
Uludağ Üniversitesi Tıp Fakültesi Dergisi
Uludağ Üniversitesi Tıp Fakültesi Dergisi
Endometrial cancer (EC) is the most common gynecological malignancy in developed countries. Obesity is known as the major risk factor for endometrial cancer. The most common subtype of endometrial cancer is endometrioid endometrial carcinoma (EEC). O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe21d3a344f22edcd22ee1f6e8275fa
https://doi.org/10.32708/uutfd.1028896
https://doi.org/10.32708/uutfd.1028896
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:1645-1649
Introduction Hyperprogression is a specific type of response seen with immunotherapy that is observed in all malignancies with a frequency of 9% - 29%, characterized by a rapid increase in tumor burden. Many possible related factors and possible mark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c33e9510921a56ca69bc8687d5b92f04
https://doi.org/10.1177/10781552221077418
https://doi.org/10.1177/10781552221077418
Autor:
burcu caner
Publikováno v:
Turkish Journal of Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa16aeca7741eb9922caaa38c9b46e2f
https://doi.org/10.5505/tjo.2023.3884
https://doi.org/10.5505/tjo.2023.3884
Autor:
Ahmet Sahin, Huseyin Melek, Birol Ocak, Sibel Orhan, Buket Erkan, Burcu Caner, Adem Deligonul, Erdem Cubukcu, Ahmet Bayram, Elif Akyildiz, Turkkan Evrensel
Publikováno v:
Mol Clin Oncol
Chemotherapy is controversial in non-metastatic typical carcinoid (TC) tumors. Therefore, it was aimed to evaluate the impact of platin-based chemotherapy on the survival of patients with lung TC. The medical records of patients who underwent surgica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d156b9bbea61bbd0f408b400a8b44c88
https://europepmc.org/articles/PMC9468804/
https://europepmc.org/articles/PMC9468804/
Publikováno v:
Kocaeli Medical Journal. 10:63-68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be11f8aaa8a773ea801d0aa828d16307
https://doi.org/10.5505/ktd.2021.96714
https://doi.org/10.5505/ktd.2021.96714
Publikováno v:
World Journal of Gastrointestinal Oncology. 12:1080-1090
The treatment of metastatic colorectal cancer (mCRC) harboring BRAF V600 mutations is challenging. These tumors are often refractory to standard treatment. Therefore, the patients may exhibit rapid clinical deterioration, depriving them of the chance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24b7e7d5bbae39eaa46522345a7be87f
https://doi.org/10.4251/wjgo.v12.i10.1080
https://doi.org/10.4251/wjgo.v12.i10.1080
Autor:
Birol OCAK, Süreyya SARIHAN, Ahmet Bilgehan ŞAHİN, Bahar DAKİKİ, Burcu CANER, Kemal GÜLŞEN, Özgür TANRIVERDİ, Adem DELİGÖNÜL, Erdem ÇUBUKÇU, Türkkan EVRENSEL
Publikováno v:
Supplement 1; Volume: 4, Issue: 71-80
Turkish Journal of Internal Medicine
Turkish Journal of Internal Medicine
Background: In non-small cell lung cancer (NSCLC), immunotherapy is a treatment option in patients without targetable mutations in second and later lines. Nevertheless, there is no validated test that can predict immunotherapy response.Material and M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b28264ae9255ef319fdfd6c27c467db
https://doi.org/10.46310/tjim.1076459
https://doi.org/10.46310/tjim.1076459
Autor:
Mehmet Çağatay Çiçek, Kazım Şenol, Gülfer Atasayar, Coşkun Ateş, Başak Erdemli Gürsel, Kadir Ömür Günseren, Yasemin Aydoğan Ünsal, Sibel Oyucu Orhan, Erdem Cubukcu, Şeyda Günay, Bedrettin Orhan, Aytül Coşar Ertem, Birol Ocak, Adem Deligonul, Seda Sali, Oktay Ünsal, Ahmet Z. Sahin, Ali Türk, Serkan Yazici, Ali Bozdağ, Burcu Caner, İbrahim Ethem Pinar, Turkkan Evrensel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45b2ce33d2a081d30f9795cf306e80c9
https://doi.org/10.37609/akya.168
https://doi.org/10.37609/akya.168